IDO1 and hepatocellular carcinoma: The results showed that IDO1 mRNA expression was strongly induced in tumour-infiltrating cells of the HCC tumour, which might facilitate an antitumour immune reaction and the expression of IDO in tissue specimens of HCC patients significantly correlated with better recurrence-free survival rates.